Cargando…
Persistence with Denosumab in Women at High Risk of Fracture in Bulgaria
INTRODUCTION: Post-menopausal women with osteoporosis > 70 years of age at high risk of fracture urgently require treatment for fracture prevention. Moreover, persistence with osteoporosis therapy is critical for real-world effectiveness. We estimated persistence with denosumab in older women at...
Autores principales: | Monov, Simeon, Nestorova, Rodina, Velkova, Margarita, Boyanov, Mihail, Jeleva, Silvia, Petkova, Renata, Petranova, Tzvetanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990988/ https://www.ncbi.nlm.nih.gov/pubmed/33555564 http://dx.doi.org/10.1007/s40744-021-00282-3 |
Ejemplares similares
-
Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment
por: Petranova, Tzvetanka, et al.
Publicado: (2014) -
Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria
por: Boyanov, Mihail A., et al.
Publicado: (2021) -
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
por: Petranova, T., et al.
Publicado: (2017) -
Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
por: Boyanov, Mihail, et al.
Publicado: (2016) -
One-year mortality after severe COPD exacerbation in Bulgaria
por: Mekov, Evgeni, et al.
Publicado: (2016)